OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma
Kausik Bishayee, Uddin Md. Nazim, Vijay Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113032-113032
Open Access | Times Cited: 15

Showing 15 citing articles:

Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9540-9540
Open Access | Times Cited: 60

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4421-4421
Open Access | Times Cited: 31

The Role of Reprogrammed Glucose Metabolism in Cancer
Meran Keshawa Ediriweera, Sharmila Jayasena
Metabolites (2023) Vol. 13, Iss. 3, pp. 345-345
Open Access | Times Cited: 21

Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation
Yunduo Liu, Yanxia Zhang, Qin Xiang, et al.
European Journal of Pharmacology (2025), pp. 177343-177343
Closed Access

Targeting tumor angiogenesis and metabolism: a new perspective in pediatric thoracic tumor therapy
Yong Lv, F. Shu, Dan Luo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development
Yanxia Zhang, Bin Xiao, Yunduo Liu, et al.
European Journal of Pharmacology (2023) Vol. 964, pp. 176304-176304
Closed Access | Times Cited: 7

Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
Francisco Irochima Pinheiro, Irami Araújo-Filho, Amália Cinhtia Meneses Rêgo, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102250-102250
Closed Access | Times Cited: 2

Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2

The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells
Kausik Bishayee, Seung-Hee Lee, Yong Soo Park
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13928-13928
Open Access | Times Cited: 3

Mocetinostat as a Novel Selective Histone Deacetylase Inhibitor in the Promotion of Apoptosis in glioblastoma Cell Line C6 and T98G
Firas Khathayer, Mohammad Hussein Mikael
Biomedical and Biotechnology Research Journal (BBRJ) (2024) Vol. 8, Iss. 3, pp. 328-339
Open Access

An altered metabolic landscape drives quiescence to the reawakening of cancer stem cells
Vijay Kumar, Kausik Bishayee
Elsevier eBooks (2023), pp. 473-483
Closed Access | Times Cited: 1

Page 1

Scroll to top